(Q39365362)

11 September 2017

title

Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro (English)

1 reference

11 September 2017

1 reference

Hai-Ling Tang

1

1 reference

11 September 2017

Yi-Qun Hu

2

1 reference

11 September 2017

Xing-Ping Qin

3

1 reference

11 September 2017

Amarsanaa Jazag

4

1 reference

11 September 2017

Hong Yang

5

1 reference

11 September 2017

Yi-Xuan Yang

6

1 reference

11 September 2017

Xiao-Ning Yang

7

1 reference

11 September 2017

Jing-Jing Liu

8

1 reference

11 September 2017

Jian-Min Chen

9

1 reference

11 September 2017

Bayasi Guleng

10

1 reference

11 September 2017

Jian-Lin Ren

11

1 reference

11 September 2017

publication date

1 August 2012

1 reference

Journal of Gastroenterology and Hepatology

11 September 2017

published in

1 reference

11 September 2017

volume

27

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

1395-1404

1 reference

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

NOEY2 mutations in primary breast cancers and breast hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Gastric epithelial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Cancer-derived VEGF plays no role in malignant ascites formation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

DNA methylation in genomic imprinting, development, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07146.X

10.1111/J.1440-1746.2012.07146.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference